Twitter | Search | |
Search Refresh
Goodwin 23 Jun 17
Goodwin advised on its $120 million :
Reply Retweet Like
Unifi Biotechnologies 1 Mar 18
, a developing red blood cell () therapies is developing replacement meds for rare conditions in which the body doesn't make an enzyme, as well as therapies that aim to re-engineer the body's system.
Reply Retweet Like
1stOncology 5 Mar 18
Reply Retweet Like
Gamer Geek Aug 4
Boston-area startups are on pace to overtake NYC venture totals
Reply Retweet Like
RegMedNet Jul 18
to spend US$155 million on a manufacturing facility.
Reply Retweet Like
Keith Croes 📰 2 Mar 18
Reply Retweet Like
IrisDorbian Jul 18
Rubius Therapeutics goes public - PE Hub:
Reply Retweet Like
IrisDorbian 9 Dec 15
PE HUB | Flagship Ventures provides $25 mln to Rubius Therapeutics:
Reply Retweet Like
News Quantified Nov 13
stock surges +24.92% after Reports of its Q3 2018 Financial Results and Operational Progress was posted
Reply Retweet Like
Brent Gregory Dec 16
San Francisco: Qatar Fund Building Venture Capital Unit for U.S. - Previous Investments Have Included and - -
Reply Retweet Like
Plexus Ventures 22 Jun 17
Reply Retweet Like
RegMedNet Jul 12
weekly: aims to advance , T cells reprogrammed without the use of viral vectors and shows confidence in red blood cell-based with new manufacturing plant.
Reply Retweet Like
6D 14 Apr 18
Biotechnologický startup vytváří geneticky upravenou ‚superkrev' pro boj s rakovinou a autoimunitními chorobami
Reply Retweet Like